Minimally Invasive Treatments for Lower Urinary Tract Symptoms: A Systematic Review
Keywords:
bladder outlet obstruction (BOO), lower urinary tract symptoms (LUTS), minimally invasive treatments (MITs), prostatic artery embolization (PAE), transurethral resection of the prostate (TURP)Abstract
Introduction: Bladder outlet obstruction (BOO) significantly contributes to lower urinary tract symptoms (LUTS) in men. When medical treatments are insufficient, surgical options such as transurethral resection of the prostate (TURP) are considered standard. However, TURP has drawbacks, including the need for general or spinal anesthesia, hospitalization, and potential complications like retrograde ejaculation, hematuria, clot retention, and urethral stricture. In response, less invasive treatments have been developed, though their functional outcomes have often been less satisfactory than TURP, leading to their exclusion from recent guidelines. Methods: A thorough search was conducted using keywords related to MITs for LUTS, with inclusion criteria focusing on randomized controlled trials (RCTs) published in English. Studies were selected based on their relevance and adherence to the inclusion criteria, followed by a rigorous quality assessment and data synthesis. Results: From an initial pool of studies, five key papers were selected for detailed analysis. These studies included comparisons of prostatic artery embolization (PAE) with TURP, aquablation with sham procedures, and various other MITs. Conclusion: This review highlights the potential of MITs as viable alternatives to TURP for treating LUTS associated with BOO. While TURP remains highly effective, MITs, particularly aquablation and PAE, offer comparable functional outcomes with better safety profiles and preservation of sexual function.
References
Cornu JN, Gacci M, Hashim H, Herrmann TRW, Malde S, Netsch C, et al. EAU guidelines on Non-Neurogenic Male Lower Urinary Tract Symptoms (LUTS), including Benign Prostatic Obstruction (BPO). [Internet] Eur. Assoc. Urol., 2023. Available at: <https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Non-Neurogenic-Male-LUTS-2022.pdf>.
Hoffman RM, MacDonald R, Monga M, Wilt TJ. Transurethral microwave thermotherapy vs transurethral resection for treating benign prostatic hyperplasia: a systematic review. BJU Int. 2004;94:1031-6.
Laguna MP, Alivizatos G, De La Rosette JJ. Interstitial laser coagulation treatment of benign prostatic hyperplasia: is it to be recommended? J Endourol. 2003;17:595-600.
Gilling P, Reuther R, Kahokehr A, Fraundorfer M. Aquablation - image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience. BJU Int. 2016;117:923-9.
Dixon CM, Rijo Cedano E, Mynderse LA, Larson TR. Transurethral convective water vapor as a treatment for lower urinary tract symptomatology due to benign prostatic hyperplasia using the Rezūm® system: evaluation of acute ablative capabilities in the human prostate. Res Rep Urol. 2015;7:13-8.
McNicholas TA, Woo HH, Chin PT, Bolton D, Fernández Arjona M, Sievert KD, et al. Minimally invasive prostatic urethral lift: surgical technique and multinational experience. Eur Urol. 2013;64:292-9.
Pisco JM, Rio Tinto H, Campos Pinheiro L, Bilhim T, Duarte M, Fernandes L, et al. Embolisation of prostatic arteries as treatment of moderate to severe lower urinary symptoms (LUTS) secondary to benign hyperplasia: results of short- and mid-term follow-up. Eur Radiol. 2013;23:2561-72.
Amparore D, De Cillis S, Volpi G, Checcucci E, Manfredi M, Morra I, et al. First- and Second-Generation Temporary Implantable Nitinol Devices As Minimally Invasive Treatments for BPH-Related LUTS: Systematic Review of the Literature. Curr Urol Rep. 2019;20:47.
McVary KT, Gange SN, Gittelman MC, Goldberg KA, Patel K, Shore ND, et al. Minimally Invasive Prostate Convective Water Vapor Energy Ablation: A Multicenter, Randomized, Controlled Study for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. J Urol. 2016;195:1529-38.
Gilling P, Barber N, Bidair M, Anderson P, Sutton M, Aho T, et al. WATER: A Double-Blind, Randomized, Controlled Trial of Aquablation® vs Transurethral Resection of the Prostate in Benign Prostatic Hyperplasia. J Urol. 2018;199:1252-61.
Sønksen J, Barber NJ, Speakman MJ, Berges R, Wetterauer U, Greene D, et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol. 2015;68:643-52.
Abt D, Hechelhammer L, Müllhaupt G, Markart S, Güsewell S, Kessler T M et al. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial BMJ 2018; 361 :k2338 doi:10.1136/bmj.k2338
Gilling, Peter; Reuther, Rana; Kahokehr, Arman; Fraundorfer, Mark (2016). Aquablation - image-guided robot-assisted waterjet ablation of the prostate: initial clinical experience. BJU International, 117(6), 923–929. doi:10.1111/bju.13358
Pisco JM, et al. Randomised Clinical Trial of Prostatic Artery Embolisation Versus a Sham Procedure for Benign Prostatic Hyperplasia. Eur Urol (2019), https://doi.org/10.1016/j.eururo.2019.11.010
Insausti I, Sáez de Ocáriz A, Galbete A, et al. Randomized Comparison of Prostatic Artery Embolization versus Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia. J Vasc Interv Radiol. 2020;31(6):882-890. doi:10.1016/j.jvir.2019.12.810
Carnevale FC, Iscaife A, Yoshinaga EM, Moreira AM, Antunes AA, Srougi M. Transurethral Resection of the Prostate (TURP) Versus Original and PErFecTED Prostate Artery Embolization (PAE) Due to Benign Prostatic Hyperplasia (BPH): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled Analysis. Cardiovasc Intervent Radiol. 2016;39(1):44-52. doi:10.1007/s00270-015-1202-4
Pisco JM, Bilhim T, Costa NV, Torres D, Pisco J, Pinheiro LC, et al. Randomised Clinical Trial of Prostatic Artery Embolisation Versus a Sham Procedure for Benign Prostatic Hyperplasia. Eur Urol. 2020;77:354-62.
McVary KT, Rogers T, Roehrborn CG. Rezūm Water Vapor Thermal Therapy for Lower Urinary Tract Symptoms Associated With Benign Prostatic Hyperplasia: 4-Year Results From Randomized Controlled Study. Urology. 2019;126:171-9.
Tanneru K, Jazayeri SB, Alam MU, Kumar J, Bazargani S, Kuntz G, et al. An Indirect Comparison of Newer Minimally Invasive Treatments for Benign Prostatic Hyperplasia: A Network Meta-Analysis Model. J Endourol. 2021;35:409- 16.
Franco JV, Jung JH, Imamura M, Borofsky M, Omar MI, Escobar Liquitay CM, et al. Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis. Cochrane Database Syst Rev. 2021;7:CD013656.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Christine, Sisca (Author)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
